How to reconstitute tirzepatide: a step-by-step protocol

Last updated 2026-07-27

what does it mean to reconstitute tirzepatide?

Reconstitution just means turning a powder back into a liquid you can inject. Compounded tirzepatide usually ships as a freeze-dried (lyophilized) powder sealed in a small glass vial. That powder is stable for a long time sitting dry, but it's useless in a syringe until you add liquid back to it. The liquid used is almost always bacteriostatic water (BAC water), sterile water with 0.9% benzyl alcohol added as a preservative. That benzyl alcohol is what lets you pull multiple doses from one vial over several weeks instead of using the whole thing in one shot and tossing the rest. Branded tirzepatide (Mounjaro and Zepbound) never requires this step. Eli Lilly ships both as ready-to-use prefilled pens or vials at fixed doses, no mixing involved, per the FDA-approved labeling for both products ^[1][2]. Reconstitution is a compounding-pharmacy thing, not a branded-drug thing. That distinction matters for anyone comparing the two: convenience is part of what you're paying for with the brand-name pen.

what supplies do you need before you start?

You need six things laid out on a clean surface before you touch the vial: the tirzepatide vial itself, bacteriostatic water, alcohol swabs, a reconstitution syringe (usually a 3 mL syringe with a drawing needle) to measure the BAC water, and a smaller insulin syringe (typically 0.5 mL, marked in units) for the actual injections later. Wash your hands first. That's not optional. Don't substitute plain sterile water for bacteriostatic water if you can avoid it. Plain sterile water has no preservative, so a multi-dose vial mixed with it should be treated as single-use and discarded within 24 hours, according to general USP compounding guidance on preservative-free preparations ^[3]. Bacteriostatic water is what makes a vial last for weeks instead of a day. Check the vial label for the total peptide content in milligrams before you do anything else. Compounded vials commonly come in strengths like 10 mg, 20 mg, 30 mg, 40 mg, or 60 mg per vial, but this varies by pharmacy and batch, so never assume. If the label is unclear or missing a mg total, stop and call the pharmacy. Guessing here is how people over- or under-dose themselves.

how much bacteriostatic water do you add to tirzepatide?

There's no single universal number here, and any article that gives you one flat ratio without asking your vial's mg strength is oversimplifying. The volume of BAC water you add is a math problem with two inputs: the total mg in the vial, and the concentration (mg per mL) you want to end up with. The general formula: BAC water volume (mL) = total vial mg ÷ desired concentration (mg/mL). So a 20 mg vial reconstituted with 2 mL of BAC water yields a 10 mg/mL solution. The same 20 mg vial with 1 mL of BAC water yields 20 mg/mL, a more concentrated (and more forgiving on syringe precision at low doses) mix. Neither is 'correct' in the abstract; it depends on what dose you're drawing and what syringe markings you're using to draw it. Here's why this matters practically: on a standard U-100 insulin syringe, 100 units = 1 mL. If your solution is 10 mg/mL, then 1 mg of tirzepatide = 10 units on that syringe. If your solution is 5 mg/mL, 1 mg = 20 units. Get the math wrong and you either overshoot into GI side effects or undershoot and wonder why the drug isn't working. This is the single most common source of dosing errors with compounded peptides, and it's entirely avoidable by writing your concentration on a piece of tape stuck to the vial the moment you mix it. Always use the exact reconstitution instructions your specific pharmacy provides for that specific vial. Compounding pharmacies vary in vial strength and packaging, and the instructions on your paperwork override any generic ratio you find online, including the illustrative math above. If you're unsure how your dose translates to a syringe reading, the Tirz Rx dosage calculator is built for exactly that conversion, and the Tirz Rx dosage guide walks through typical titration schedules.

step-by-step: how do you actually mix the vial?

Once you know your target volume, the mixing itself is mechanical and takes about two minutes. 1. Wipe the rubber stopper on both the BAC water vial and the tirzepatide vial with a fresh alcohol swab. Let it air dry for a few seconds. 2. Draw the calculated amount of bacteriostatic water into your reconstitution syringe. Draw a little air into the syringe first (equal to the volume you're withdrawing) and inject that air into the BAC water vial before drawing the liquid; this equalizes pressure and makes the draw smoother. 3. Insert the needle into the tirzepatide vial at an angle, resting the needle tip against the inside glass wall, not pointed straight down at the powder. 4. Push the plunger slowly, letting the water run down the glass and settle over the powder gradually rather than blasting it directly. 5. Remove the needle. Gently swirl or roll the vial between your palms. Never shake it. Tirzepatide is a peptide, and peptides have a folded structure held together by weak bonds; vigorous shaking creates mechanical stress and air bubbles that can denature the protein, potentially reducing potency or encouraging aggregation. Swirling is slower but it protects the molecule. 6. Let it sit for a minute or two, then check it. Properly reconstituted tirzepatide solution should be clear and colorless. Any cloudiness, visible particles, or discoloration means don't use it. 7. Label the vial immediately with the date and the final concentration (mg/mL). This step is the one people skip and later regret.

how do you know if the tirzepatide didn't reconstitute properly?

The main visual check is clarity. A correctly mixed vial looks like water, completely clear, no floaters, no haze, no color tint beyond maybe the faintest tinge. If you see cloudiness that doesn't clear after a few minutes of gentle swirling, or any visible particulate matter, that vial is compromised and shouldn't be injected. Cloudiness after mixing usually points to one of three things: the powder wasn't given enough time or gentle agitation to fully dissolve, the vial was shaken hard enough to cause protein aggregation, or the vial had already started degrading before you added water (heat exposure during shipping is the usual culprit there). If a vial won't clear up after a reasonable amount of gentle swirling over several minutes, don't force it by shaking harder. Contact the pharmacy that supplied it. A pharmacy standing behind provider-reviewed sourcing should replace a vial that failed to reconstitute properly; that's part of what you're paying for when you go through a legitimate channel instead of an anonymous online seller.

how long does reconstituted tirzepatide last, and how should you store it?

Once mixed, tirzepatide needs to live in the refrigerator, generally cited in the 36°F to 46°F (2°C to 8°C) range, and out of light. Most compounding pharmacies label reconstituted vials for use within 14 to 28 days refrigerated, though the exact window depends on that pharmacy's own stability testing and should be printed on your vial label. Some pharmacies state shorter windows for vials mixed with plain sterile water versus bacteriostatic water, because the preservative in BAC water is what extends usable life. Don't freeze it. Freezing and thawing stresses the peptide structure the same way shaking does, and can leave you injecting a less potent (or completely inactive) solution without any visible sign that anything's wrong. Don't leave it at room temperature for extended periods either. Brief time out of the fridge to warm slightly before injection (reducing injection-site sting) is fine, ten to fifteen minutes on the counter, but the vial's default home is the fridge door or a dedicated shelf, not the counter and not the freezer door where temperature swings are worse. Write the reconstitution date on the vial the day you mix it. Counting days in your head is how people end up injecting week-6 solution they believed was week-3.

how do you draw and inject a dose after reconstitution?

Once the vial is mixed, dosing is a separate skill from mixing, and it deserves its own attention. Wipe the stopper again with a fresh alcohol swab before every single draw, more than the first one. Draw slightly more air into your insulin syringe than the units you need, inject that air into the vial to equalize pressure, then invert the vial and draw your dose slowly, checking for air bubbles in the syringe before you pull the needle out. Rotate injection sites between doses. The three standard subcutaneous sites are the abdomen (at least two inches from the navel), the front of the thigh, and the back of the upper arm; the Tirz Rx injection sites guide covers rotation patterns in more depth, and Tirz Rx how to inject walks through injection technique itself, angle, depth, and aftercare. Tirzepatide's long elimination half-life, approximately 5 days according to the FDA label for Zepbound and Mounjaro ^[2][1], is why dosing is weekly rather than daily. That long half-life is also why missing the exact day by a day or two doesn't meaningfully change blood levels; see the Tirz Rx half life page for how that timing math actually works, and how it interacts with cycle planning.

compounded tirzepatide vs. branded Mounjaro and Zepbound: what's the real difference?

This is worth being direct about, because the two products are not interchangeable in regulatory status even though the active molecule is the same peptide. Mounjaro (tirzepatide) was approved by the FDA in May 2022 for type 2 diabetes, based on the SURPASS trial program. SURPASS-2 (NCT03987919), for example, compared tirzepatide against semaglutide 1 mg in adults with type 2 diabetes and found tirzepatide produced significantly greater reductions in A1C, with the 15 mg dose lowering A1C by 2.30 percentage points versus 1.86 for semaglutide over 40 weeks ^[4]. Zepbound (tirzepatide) was approved in November 2023 specifically for chronic weight management, based on the SURMOUNT trial program. SURMOUNT-1 (NCT04184622) enrolled adults with obesity or overweight without diabetes and found the 15 mg dose produced an average 20.9% body weight reduction at 72 weeks, versus 3.1% for placebo ^[5]. Both are FDA-approved, manufactured under FDA quality oversight, and come as ready-to-use pens, no reconstitution needed. Compounded tirzepatide is different. It's produced by state-licensed compounding pharmacies, typically under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act, which allows compounding when a drug is on the FDA's shortage list or for patient-specific formulation needs. The FDA has been explicit that compounded versions are not FDA-approved and haven't gone through the same premarket review for safety, efficacy, and manufacturing consistency that Mounjaro and Zepbound have ^[6]. That doesn't automatically make a specific pharmacy's product unsafe, but it does mean the quality assurance rests on that individual pharmacy's practices, not on an FDA approval. Sourcing through a provider-reviewed pathway, where a licensed prescriber and a vetted pharmacy are both part of the chain, is a meaningfully different risk profile than buying loose vials off a marketplace with no clinical oversight.

what side effects and safety warnings should you know before starting?

Tirzepatide's side effect profile is well documented across both the SURPASS and SURMOUNT trial programs, and it isn't mild for everyone. Gastrointestinal effects are the most common by far: nausea, diarrhea, vomiting, constipation, and decreased appetite. In SURMOUNT-1, nausea occurred in roughly 24-33% of participants across dose groups compared to about 10% on placebo, and these effects were most frequent during dose escalation ^[5]. The FDA label for both Mounjaro and Zepbound carries a boxed warning for thyroid C-cell tumors, based on findings in rodent studies; tirzepatide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) ^[1][2]. This is not a footnote. Anyone with that family history should not be taking this drug, compounded or branded, without a very direct conversation with a prescriber first. Other signals from the trial data and label include acute pancreatitis (a small but real signal across the GLP-1/GIP class), gallbladder disease including cholelithiasis and cholecystitis, acute kidney injury (often secondary to dehydration from GI side effects), and hypoglycemia risk when combined with insulin or sulfonylureas ^[1][2]. Severe abdominal pain that doesn't go away, or persistent vomiting, is a reason to stop and call a doctor, not push through. None of this is unique to compounded product versus branded product; it's the pharmacology of tirzepatide itself, GLP-1 and GIP receptor agonism slows gastric emptying and that's both the mechanism for weight loss and the mechanism for the nausea.

common reconstitution mistakes that ruin a vial or a dose

A short, blunt list, because most of the real-world problems repeat: Shaking the vial instead of swirling it. This is the single most common mistake and the easiest to avoid. Peptides are fragile to mechanical stress; treat the vial like a raw egg, not a paint can. Using the wrong needle angle so the water blasts directly onto the powder instead of running down the glass wall. This causes foaming and uneven mixing. Mixing math errors, adding a 'standard' amount of BAC water without checking the actual mg on that specific vial. Every vial's labeled strength should be double-checked, every time, especially if you're getting vials from different batches or, worse, different pharmacies. Skipping the label step and losing track of the reconstitution date, leading to using expired mixed solution weeks past the pharmacy's stated window. Storing at room temperature for convenience 'just this once.' Heat degrades peptides faster than almost anything else you control day to day. Reusing needles across multiple draws from the same vial. Beyond infection risk, a dulled needle damages the rubber stopper, which can lead to coring, tiny bits of rubber falling into the solution.

where does compounded tirzepatide fit if you're deciding how to start?

For most people weighing this decision, the honest framing is: branded Mounjaro or Zepbound gives you FDA-approved manufacturing consistency and zero mixing, at a higher list price and often with insurance coverage hurdles depending on your plan and diagnosis. Compounded tirzepatide, sourced through a provider-reviewed pathway with real clinical oversight, is a lower-cost route that shifts more responsibility onto you (and the pharmacy) for correct handling, but it is not FDA-approved and doesn't carry the same premarket safety and manufacturing review ^[6]. If you go the compounded route, reconstitution technique is the part of the process you actually control. Good technique doesn't make an unapproved product equivalent to an approved one, but bad technique (shaking, wrong ratios, room-temperature storage, expired vials) adds a second, avoidable layer of risk on top of the first. A provider-reviewed pathway, where a clinician evaluates you, prescribes, and a named compounding pharmacy fulfills that prescription, is the version of this that has actual oversight built in, as opposed to buying vials from an unverified online seller with no prescriber involved at all. Tirz Rx's provider-reviewed model connects patients to that kind of pathway, with fulfillment handled by a licensed pharmacy partner, rather than compounding or shipping product itself.

Frequently asked questions

How much bacteriostatic water do I mix with tirzepatide?

It depends on your vial's total mg and your target concentration; there's no single universal ratio. The formula is BAC water (mL) = total vial mg ÷ desired mg/mL concentration. A 20 mg vial with 2 mL of water yields 10 mg/mL. Always follow the specific instructions provided with your vial, since compounding pharmacies vary in strength and packaging.

Can I use regular water instead of bacteriostatic water?

You shouldn't. Bacteriostatic water contains 0.9% benzyl alcohol as a preservative, which is what allows a multi-dose vial to stay usable for weeks. Plain sterile water has no preservative, so under general USP compounding guidance, a vial mixed with it should be treated as single-use and discarded within 24 hours.

Why does my reconstituted tirzepatide look cloudy?

Cloudiness usually means incomplete mixing, protein aggregation from shaking too hard, or degradation from heat exposure before you even opened it. A properly mixed solution should be clear and colorless. If gentle swirling doesn't clear it within a few minutes, don't inject it; contact the supplying pharmacy for a replacement.

How long can reconstituted tirzepatide sit in the fridge?

Most compounding pharmacies label reconstituted vials for 14 to 28 days when refrigerated between roughly 36°F and 46°F (2°C to 8°C), though the exact window depends on that pharmacy's stability data and should be printed on your vial. Never freeze it, and don't leave it at room temperature beyond brief pre-injection warming.

Do I shake or swirl the vial when reconstituting?

Swirl gently, never shake. Tirzepatide is a peptide held together by weak molecular bonds, and vigorous shaking creates mechanical stress that can denature the protein or cause visible aggregation and foaming. Roll the vial gently between your palms and let it sit for a minute or two after mixing.

Is compounded tirzepatide the same as Mounjaro or Zepbound?

The active molecule is the same, but the regulatory status isn't. Mounjaro and Zepbound are FDA-approved, manufactured under FDA oversight, and require no reconstitution. Compounded tirzepatide is made by licensed compounding pharmacies under FDCA Section 503A or 503B, but per the FDA, compounded drugs are not FDA-approved and haven't undergone the same premarket safety review.

What syringe do I use to inject reconstituted tirzepatide?

A standard U-100 insulin syringe, typically 0.5 mL or 1 mL marked in units, is used for the actual injection after you've mixed the vial with a separate 3 mL reconstitution syringe. On a U-100 syringe, 100 units equals 1 mL, so your dose in units depends entirely on your mixed concentration in mg/mL.

What happens if I inject expired reconstituted tirzepatide?

Past the pharmacy's labeled window (commonly 14 to 28 days refrigerated), the peptide may have degraded, meaning you could be injecting a less potent solution without any visible warning sign. It's not necessarily dangerous in the way spoiled food is, but you risk under-dosing without knowing it. Discard and contact the pharmacy instead of guessing.

What are the main side effects of tirzepatide?

Gastrointestinal effects dominate: nausea, diarrhea, vomiting, constipation, and reduced appetite, most common during dose escalation. In SURMOUNT-1, nausea occurred in roughly 24 to 33% of tirzepatide participants versus about 10% on placebo. Less common but serious risks include pancreatitis, gallbladder disease, and kidney injury from dehydration.

Who should not take tirzepatide?

Anyone with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not take tirzepatide; both Mounjaro and Zepbound carry an FDA boxed warning for thyroid C-cell tumors based on rodent studies. This applies to compounded and branded tirzepatide equally, since it's a property of the molecule.

How do I know what concentration my reconstituted vial is?

Divide the total mg labeled on the vial by the mL of bacteriostatic water you added. A 30 mg vial mixed with 3 mL yields 10 mg/mL. Write this number on the vial immediately after mixing; it's the single most important number for converting your prescribed dose into a syringe unit reading.

Can reconstituted tirzepatide be frozen for longer storage?

No. Freezing and thawing stresses the peptide's structure similarly to shaking, and can reduce potency or damage the molecule without any visible change in the liquid's appearance. Reconstituted tirzepatide should stay refrigerated, not frozen, and should be used within the pharmacy's stated window.

Sources

1. FDA, Mounjaro (tirzepatide) prescribing information: Boxed warning for thyroid C-cell tumors, half-life of approximately 5 days, and ready-to-use pen formulation for Mounjaro
2. FDA, Zepbound (tirzepatide) prescribing information: Boxed warning for thyroid C-cell tumors and ready-to-use pen formulation for Zepbound
3. USP General Chapter <797>, Pharmaceutical Compounding Sterile Preparations: Preservative-free preparations have shorter beyond-use dating than preserved multi-dose preparations
4. ClinicalTrials.gov, SURPASS-2 (NCT03987919): SURPASS-2 compared tirzepatide to semaglutide 1 mg in type 2 diabetes and found greater A1C reduction with tirzepatide
5. ClinicalTrials.gov, SURMOUNT-1 (NCT04184622): SURMOUNT-1 measured body weight reduction and adverse events including nausea rates for tirzepatide vs placebo over 72 weeks
6. FDA, Compounding and the FDA: Questions and Answers: Compounded drugs are not FDA-approved and do not undergo the same premarket review for safety, effectiveness, and quality as approved drugs